Mayne Pharma Inc

FDA recalling firm · 6 enforcement events · 6 product records · 2017–2022 · NC

Mayne Pharma Inc has 6 FDA enforcement events on this register (6 product records) between 2017 and 2022: 6 drug; the busiest year was 2018 with 2.

0% of its events are Class I; the most common class is Class II (4). 1 event is listed as ongoing; the recalling firm's address is in NC.

Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.

Enforcement events

Initiated	Product (first record)	Type	Class	Records	Status
9 Jun 2022	Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834	Drug	Class II	1	Terminated
14 Jan 2022	Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne Pharma Greenville, NC 27834, NDC 51862-604-50	Drug	Class II	1	Ongoing
2 Mar 2020	Carbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834. NDC 51862-858-01	Drug	Class II	1	Terminated
21 Aug 2018	Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01.	Drug	Class III	1	Terminated
21 Mar 2018	Fabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834; NDC 51862-295-10.	Drug	Class III	1	Terminated
9 Nov 2017	Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01	Drug	Class II	1	Terminated

By type and class

Drug6

Class II4

Class III2

Class I: 0% of this firm's events; 18% of all events on the register.

Events by year

Enforcement events for Mayne Pharma Inc by year initiated.

Questions and answers

How many FDA recalls has Mayne Pharma Inc had?

6 enforcement events (6 product records) on this register, 2017–2022: 6 drug.

Are any Mayne Pharma Inc recalls ongoing?

1 event is listed as ongoing in the current openFDA export.

What class are Mayne Pharma Inc recalls?

4 Class II, 2 Class III. 0% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.

Where does this data come from?

openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.

Provenance

Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.